RONALD CAPORALE: Open Payments
NPI 1316294408 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,147 in 141 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,073 · 2025 $3,147
Food & beverage: $3,047Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $870 |
| ARS Pharmaceuticals Operations, Inc. | 13 | $323 |
| CSL Behring | 18 | $305 |
| GlaxoSmithKline, LLC. | 19 | $273 |
| Amgen Inc. | 23 | $250 |
| Verona Pharma, Inc. | 16 | $221 |
| Galderma Laboratories, L.P. | 2 | $159 |
| Pharming Healthcare, Inc. | 10 | $157 |
| Novartis Pharmaceuticals Corporation | 4 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
Products named: TEZSPIRE, NEFFY, FASENRA, AIRSUPRA, Ohtuvayre, Hizentra, DUPIXENT, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
